Health
Researchers test novel gene regulation approach to treat brain diseases – News-Medical.Net
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation…
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer’s in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it, thereby reducing Tau production in the brain and preventing nerve damage. The preclinical results, published in the journal Science Advances,…
-
Noosa News21 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business23 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News9 hours agoHelp to make recycling stick
-
General23 hours agoTrump threatens Aussie medicines with bitter tax pill